Umeclidinium Bromide Powder for Inhalation

Glaxo Group Ltd.🇨🇳 National Medical Products Administration

Approval Id: 7ucivOFN6xg
Approval Number: H20190070
Generic Name: 乌美溴铵吸入粉雾剂
Generic Name En: Umeclidinium Bromide Powder for Inhalation
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 乌美溴铵(以乌美铵计)62.5μg
Reg Date: 2019-12-26
Expired Date: 2024-12-25
Company Name: Glaxo Group Ltd.
Company Address: 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom
Production Company Name: Glaxo Operations UK Ltd.
Production Company Address: Priory Street,Ware,Hertfordshire SG12 0DJ,United Kingdom
Company Detail Path: /organization/glaxo-group-ltd
Production Company Detail Path: /organization/glaxo-operations-uk-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 26, 2019

Approval ID

7ucivOFN6xg

Type

化学药品